SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

INVISTA, Solvay Sign New JV Agreement Settling IP Disputes over Butachimie Joint Venture

INVISTA and Solvay have signed a settlement agreement that resolves disputes related to adiponitrile (ADN) intellectual property and technology in use at their nylon 6,6 intermediates Butachimie joint venture in Chalampé, France.

The settlement confirms INVISTA’s exclusive ownership of the ADN technology at Butachimie and includes a plan to upgrade the facility with INVISTA’s latest and most advanced ADN technology. The planned upgrade would be one of several components in a new joint venture relationship between the two companies.

“Retrofitting Butachimie with INVISTA’s newest ADN technology will dramatically increase the plant’s efficiency,” said Warren Primeaux, president of INVISTA Intermediates. “Under this new joint venture, we are excited to work together with Solvay to better serve our customers and support nylon 6,6 growth.”

The Butachimie joint venture has been operating for 40 years, and is the world’s largest ADN facility. The nylon 6,6 intermediates made at Butachimie are used to make nylon 6,6 fibers and polymers that ultimately become part of air bags, automobile parts, carpet, workout apparel, outdoor equipment and more.

About INVISTA

With leading brands including LYCRA®, COOLMAX®, CORDURA®, STAINMASTER® and ANTRON®, INVISTA is one of the world’s largest integrated producers of chemical intermediates, polymers and fibers. The company’s advantaged technologies for nylon, spandex and polyester are used to produce clothing, carpet, car parts and countless other everyday products. Headquartered in the United States, INVISTA operates in more than 20 countries and has about 10,000 employees. For more information, visit INVISTA.com, Facebook.com/INVISTAglobal and Twitter.com/INVISTA.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.